VF
MRM

Virtu Financial’s MEDIROM Healthcare Technologies MRM Stock Holding History

Virtu Financial’s Portfolio MRM Stock Details MRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Buy
+15,785
New +$17.7K ﹤0.01% 1377
2024
Q4 		– Sell
-10,942
Closed -$33K – 1858
2024
Q3 		$33K Buy
+10,942
New +$40.9K ﹤0.01% 1066

Other funds holding MRM

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Virtu Financial's MRM Position: Q2 2026 in Review

Virtu Financial opened a new position in MEDIROM Healthcare Technologies (MRM) in Q2 2026: 15,785 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #1377 among its holdings. This is a return to the name: Virtu Financial previously reported a position in MRM as recently as Q3 2024.

Virtu Financial first reported a position in MRM in Q3 2024 and has held it in 2 quarters since. The position peaked at $33K in Q3 2024. 8 funds tracked by Wall St. Rank hold MRM as of Q2 2026.

  • Virtu Financial held 15,785 shares of MEDIROM Healthcare Technologies worth $16K as of Q2 2026.
  • MEDIROM Healthcare Technologies was a new Virtu Financial position in Q2 2026.
  • MEDIROM Healthcare Technologies made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1377 holding.
  • Virtu Financial first reported a position in MEDIROM Healthcare Technologies in Q3 2024 and has held it in 2 quarters since.
  • Virtu Financial's MEDIROM Healthcare Technologies position peaked at $33K in Q3 2024.
  • 8 funds tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.